Efficacy of arterial spin labeling magnetic resonance perfusion in differentiating recurrent or residual high-grade glioma from post-treatment changes: A retrospective hospital-based study.
4 affiliations
- 1Department of Neurosurgery, Mahatma Gandhi Medical College and Hospital, Jaipur, Rajasthan, India.
- 2Department of Neurosurgery, Mahatma Gandhi University of Sciences and Technology, Gorakhpur, Uttar Pradesh, India.
- 3Department of Neurosurgery, Mahatma Gandhi University of Medical Sciences and Technology, Jaipur, Rajasthan, India.
- 4Department of Radiology, Mahatma Gandhi Medical College and Hospital, Jaipur, Rajasthan, India.
Abstract
Background
Differentiating true recurrence or residual disease from treatment-related changes in patients treated for high-grade glioma (HGG) remains a major diagnostic challenge, because both produce contrast- enhancing lesions on conventional magnetic resonance imaging (MRI). Arterial spin labeling (ASL) is a non- contrast perfusion technique that quantifies cerebral blood flow using magnetically labeled arterial blood water as an endogenous tracer. We evaluated the efficacy of ASL magnetic resonance (MR) perfusion in distinguishing recurrent or residual HGG from post-treatment changes.Methods
This retrospective hospital-based study analysed 71 patients (>18 years) with histopathologically proven GRADE 3 and 4 GLIOMA who had received post-operative radiotherapy and/or chemotherapy and presented with a focal enhancing lesion. All had undergone 3.0 T MRI, including three-dimensional pseudo- continuous ASL. Relative cerebral blood flow (rCBF) and qualitative perfusion pattern (red/hyperperfusion vs. blue/hypoperfusion) were correlated against a reference standard of histopathology (n = 22) or a predefined composite clinico-radiological standard based on ≥6 months of serial follow-up imaging (n = 49); tumors were classified per the World Health Organization 2021 central nervous system classification. Diagnostic performance and a receiver operating characteristic (ROC) cutoff were derived.Results
Recurrence/residual disease was confirmed in 21 patients (29.6%) and post-treatment change in 50 (70.4%). Mean rCBF was significantly higher in recurrence (2.33 ± 0.602) than in post-treatment change (1.058 ± 0.302; Mann-Whitney U, p < 0.0001). The red perfusion pattern was seen in 20 of 21 recurrences and only 1 of 50 post-treatment cases (p < 0.0001). ASL achieved sensitivity 95.0%, specificity 98.0%, positive predictive value 95.0%, negative predictive value 98.0% and accuracy 97.1%, with almost-perfect agreement with the reference standard (κ = 0.93). ROC analysis yielded an area under the curve of 0.911 with an optimal rCBF cutoff of 2.04 (sensitivity 90.0%, specificity 98.0%). Diagnostic performance was comparable in the histopathology-confirmed subgroup (accuracy 95.5%) and the follow-up-confirmed subgroup (accuracy 98.0%).Conclusion
ASL MR perfusion is a reliable, reproducible and contrast-free technique with excellent accuracy for differentiating recurrent or residual HGG from post-treatment changes, and is well suited to longitudinal surveillance where repeated gadolinium administration is undesirable.
Related
- Quantitative Pharmacokinetic Analysis of Dynamic Contrast-Enhanced Perfusion in Multiparametric Prostate MRI: An Exploratory Intra-Patient Study Differentiating Malignant Lesions from Normal Tissue
- Vascular habitat analysis using dynamic susceptibility contrast-enhanced perfusion MRI for differentiating glioblastoma from solitary brain metastases.
- Left ventricular function and volumes from cardiac magnetic resonance and gated [13N]-ammonia positron emission tomography myocardial perfusion imaging in patients with ischemia with no obstructive coronary arteries: a prospective head-to-head comparison using hybrid positron emission tomography/magnetic resonance
- Development of a nomogram integrating contrast-enhanced magnetic resonance imaging radiomics and clinical parameters for differentiating brain metastases of bronchial carcinoma from cerebral tuberculomas.
- Relative CT Number as a Quantitative Imaging Biomarker for Differentiating Sinonasal Polyp, Inverted Papilloma, and Squamous Cell Carcinoma: A Preliminary Retrospective Study
BibTeX
@article{rana2026efficacy,
title = {{Efficacy of arterial spin labeling magnetic resonance perfusion in differentiating recurrent or residual high-grade glioma from post-treatment changes: A retrospective hospital-based study.}},
author = {Rahul Rajendrakumar Rana and Anurag Srivastava and Viraj Dipak Narola and Rohin Bhatia and Vineet Mishra and Bhawani Shankar Sharma and Pankaj Gupta and Jitendra Singh Verma and Sameer Narad and Sandharbh Gautam and Foram Mehta},
journal = {Surgical neurology international},
year = {2026},
month = oct,
doi = {10.25259/sni_765_2026},
url = {https://europepmc.org/article/MED/42974537},
note = {CC BY-NC-SA},
}
RIS
TY - JOUR
TI - Efficacy of arterial spin labeling magnetic resonance perfusion in differentiating recurrent or residual high-grade glioma from post-treatment changes: A retrospective hospital-based study.
AU - Rahul Rajendrakumar Rana
AU - Anurag Srivastava
AU - Viraj Dipak Narola
AU - Rohin Bhatia
AU - Vineet Mishra
AU - Bhawani Shankar Sharma
AU - Pankaj Gupta
AU - Jitendra Singh Verma
AU - Sameer Narad
AU - Sandharbh Gautam
AU - Foram Mehta
PY - 2026
DA - 2026/10/16
JO - Surgical neurology international
DO - 10.25259/sni_765_2026
UR - https://europepmc.org/article/MED/42974537
AB - Background Differentiating true recurrence or residual disease from treatment-related changes in patients treated for high-grade glioma (HGG) remains a major diagnostic challenge, because both produce contrast- enhancing lesions on conventional magnetic resonance imaging (MRI). Arterial spin labeling (ASL) is a non- contrast perfusion technique that quantifies cerebral blood flow using magnetically labeled arterial blood water as an endogenous tracer. We evaluated the efficacy of ASL magnetic resonance (MR) perfusion in distinguishing recurrent or residual HGG from post-treatment changes.Methods This retrospective hospital-based study analysed 71 patients (>18 years) with histopathologically proven GRADE 3 and 4 GLIOMA who had received post-operative radiotherapy and/or chemotherapy and presented with a focal enhancing lesion. All had undergone 3.0 T MRI, including three-dimensional pseudo- continuous ASL. Relative cerebral blood flow (rCBF) and qualitative perfusion pattern (red/hyperperfusion vs. blue/hypoperfusion) were correlated against a reference standard of histopathology (n = 22) or a predefined composite clinico-radiological standard based on ≥6 months of serial follow-up imaging (n = 49); tumors were classified per the World Health Organization 2021 central nervous system classification. Diagnostic performance and a receiver operating characteristic (ROC) cutoff were derived.Results Recurrence/residual disease was confirmed in 21 patients (29.6%) and post-treatment change in 50 (70.4%). Mean rCBF was significantly higher in recurrence (2.33 ± 0.602) than in post-treatment change (1.058 ± 0.302; Mann-Whitney U, p < 0.0001). The red perfusion pattern was seen in 20 of 21 recurrences and only 1 of 50 post-treatment cases (p < 0.0001). ASL achieved sensitivity 95.0%, specificity 98.0%, positive predictive value 95.0%, negative predictive value 98.0% and accuracy 97.1%, with almost-perfect agreement with the reference standard (κ = 0.93). ROC analysis yielded an area under the curve of 0.911 with an optimal rCBF cutoff of 2.04 (sensitivity 90.0%, specificity 98.0%). Diagnostic performance was comparable in the histopathology-confirmed subgroup (accuracy 95.5%) and the follow-up-confirmed subgroup (accuracy 98.0%).Conclusion ASL MR perfusion is a reliable, reproducible and contrast-free technique with excellent accuracy for differentiating recurrent or residual HGG from post-treatment changes, and is well suited to longitudinal surveillance where repeated gadolinium administration is undesirable.
SN - 2229-5097
SN - 2152-7806
ER -